ESR2 and melanoma: Here, we demonstrated the ability of this compound to affect melanoma cell proliferation with minimal toxicity on normal cells (Fig. S1), inducing cell cycle arrest in G2/M phase in agreement with the absolute amount of ERβ or the relative expression of ERα and ERβ in each melanoma cell line (Fig. 3A, S2).